Selection of patients for bone marrow transplantation in severe aplastic anemia.

Despite androgens and intensive supportive care, satisfactory survival in severe aplastic anemia remains at 20% or less. Histocompatible bone marrow transplantation can restore normal hematopoiesis in approximately 40% of similarly severe individuals. Delay of transplantation for 3 wk after diagnosis allows time for proper evaluation and for many spontaneous recoveries. Further delay increases risks of fatal complications and decreases chances for successful transplantation while the incidence of spontaneous remission declines. When available, early histocompatible bone marrow transplantation may be the treatment of choice for severe aplastic anemia.

[1]  G. Bodey,et al.  Effect of prophylactic measures on the microbial flora of patients in protected environment units. , 1974, Medicine.

[2]  D. Nathan,et al.  Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. , 1974, Blood.

[3]  R. Storb,et al.  Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum. , 1974, Journal of immunology.

[4]  P. Neiman,et al.  Allogeneic marrow grafting for treatment of aplastic anemia. , 1974, Blood.

[5]  R. Lynch,et al.  Drug-induced aplastic anemia. , 1973, Seminars in hematology.

[6]  S. Perry,et al.  Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. , 1973, The New England journal of medicine.

[7]  S. Perry,et al.  Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. , 1972, The New England journal of medicine.

[8]  F. Li,et al.  The mortality of acquired aplastic anemia in children. , 1972, Blood.

[9]  A. Rubin,et al.  TREATMENT AND PROGNOSIS IN APLASTIC ANÆMIA , 1972 .

[10]  M. Willoughby Treatment and prognosis in aplastic anemia. , 1972, Lancet.

[11]  L. Sánchez-Medal,et al.  Androstane therapy of aplastic anaemia. , 1972, Acta haematologica.

[12]  R. Slavin,et al.  Marrow transplanation in man following cyclophosphamide. , 1971, Transplantation proceedings.

[13]  L. Sánchez-Medal The hemopoietic action of androstanes. , 1971, Progress in hematology.

[14]  R Revol Núñez,et al.  [Aplastic anemia]. , 1970, Archivos Argentinos de Pediatria.

[15]  A. Newman,et al.  Acute childhood leukemia presenting as aplastic anemia: the response to corticosteroids. , 1970, The Journal of pediatrics.

[16]  R Storb,et al.  Technique for human marrow grafting. , 1970, Blood.

[17]  R. Storb,et al.  The effect of prior transfusion on marrow grafts between histocompatible canine siblings. , 1970, Journal of immunology.

[18]  F. Grumet,et al.  Long-term platelet support of patients with aplastic anemia. Effect of splenectomy and steroid therapy. , 1970, Annals of internal medicine.

[19]  L. Sánchez-Medal,et al.  Anabolic androgenic steroids in the treatment of acquired aplastic anemia. , 1969, Blood.

[20]  R. Heyn,et al.  Course of acquired aplastic anemia in children treated with supportive care. , 1969, JAMA.

[21]  L. Diamond,et al.  Testosterone-induced remission in aplastic anemia of both acquired and congenital types. Further observations in 24 cases. , 1961, The New England journal of medicine.

[22]  C. P. Rhoads,et al.  REFRACTORY ANAEMIAII. AETIOLOGY AND TREATMENT , 1941 .